Morgan Stanley
LSTA icon

Morgan Stanley’s Lisata Therapeutics LSTA Stock Holding History

Morgan Stanley’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$376 Hold
75
– – ﹤0.01% 7648
2025
Q4 		$140 Sell
75
-133
-64% -$296 ﹤0.01% 7670
2025
Q3 		$545 Sell
208
-16
-7% -$40 ﹤0.01% 7481
2025
Q2 		$649 Sell
224
-1,242
-85% -$2.99K ﹤0.01% 7389
2025
Q1 		$3.45K Hold
1,466
– – ﹤0.01% 7076
2024
Q4 		$4.37K Hold
1,466
– – ﹤0.01% 7041
2024
Q3 		$4.4K Sell
1,466
-1,084
-43% -$3.42K ﹤0.01% 6949
2024
Q2 		$8.85K Hold
2,550
– – ﹤0.01% 6717
2024
Q1 		$7.96K Sell
2,550
-2,550
-50% -$7.55K ﹤0.01% 6779
2023
Q4 		$13.9K Buy
5,100
+2,001
+65% +$4.7K ﹤0.01% 6760
2023
Q3 		$6.63K Sell
3,099
-11,024
-78% -$30.6K ﹤0.01% 6848
2023
Q2 		$52.3K Buy
14,123
+12,574
+812% +$45.7K ﹤0.01% 6194
2023
Q1 		$5.03K Hold
1,549
– – ﹤0.01% 7051
2022
Q4 		$3.92K Buy
1,549
+133
+9% +$488 ﹤0.01% 7212
2022
Q3 		$7K Sell
1,416
-502
-26% -$3.64K ﹤0.01% 7180
2022
Q2 		$15K Buy
1,918
+5
+0.3% +$41 ﹤0.01% 7098
2022
Q1 		$21K Sell
1,913
-2,490
-57% -$28.5K ﹤0.01% 7126
2021
Q4 		$55K Buy
4,403
+913
+26% +$14.1K ﹤0.01% 6763
2021
Q3 		$64K Sell
3,490
-923
-21% -$18.1K ﹤0.01% 6604
2021
Q2 		$106K Sell
4,413
-289
-6% -$6.85K ﹤0.01% 6334
2021
Q1 		$137K Buy
4,702
+3,959
+533% +$120K ﹤0.01% 5857
2020
Q4 		$16K Buy
743
+22
+3% +$522 ﹤0.01% 6501
2020
Q3 		$20K Buy
721
+474
+192% +$15K ﹤0.01% 6065
2020
Q2 		$7K Buy
247
+96
+64% +$2.82K ﹤0.01% 6242
2020
Q1 		$4K Sell
151
-7
-4% -$272 ﹤0.01% 6271
2019
Q4 		$6K Buy
158
+13
+9% +$467 ﹤0.01% 6373
2019
Q3 		$6K Sell
145
-175
-55% -$6.8K ﹤0.01% 6333
2019
Q2 		$11K Sell
320
-146
-31% -$6.49K ﹤0.01% 6103
2019
Q1 		$25K Buy
466
+320
+219% +$21K ﹤0.01% 5940
2018
Q4 		$8K Sell
146
-202
-58% -$14K ﹤0.01% 6214
2018
Q3 		$31K Buy
348
+281
+419% +$23K ﹤0.01% 6017
2018
Q2 		$6K Buy
67
+64
+2,133% +$4.51K ﹤0.01% 6404
2018
Q1 		$0 Hold
3
– – ﹤0.01% 6660
2017
Q4 		$0 Hold
3
– – ﹤0.01% 6613
2017
Q3 		$0 Buy
3
+2
+200% +$121 ﹤0.01% 6572
2017
Q2 		$0 Sell
1
-234
-100% -$16.5K ﹤0.01% 6621
2017
Q1 		$18K Sell
235
-121
-34% -$8.38K ﹤0.01% 6114
2016
Q4 		$15K Buy
356
+338
+1,878% +$19.4K ﹤0.01% 6067
2016
Q3 		$1K Buy
18
+3
+20% +$242 ﹤0.01% 6429
2016
Q2 		$1K Hold
15
– – ﹤0.01% 6431
2016
Q1 		$2K Sell
15
-27
-64% -$2.65K ﹤0.01% 6399
2015
Q4 		$7K Sell
42
-80
-66% -$14.7K ﹤0.01% 6316
2015
Q3 		$27K Sell
122
-1,229
-91% -$308K ﹤0.01% 5949
2015
Q2 		$379K Buy
1,351
+1,119
+482% +$416K ﹤0.01% 4901
2015
Q1 		$89K Sell
232
-30
-11% -$16.3K ﹤0.01% 5579
2014
Q4 		$148K Buy
262
+50
+24% +$34K ﹤0.01% 5384
2014
Q3 		$176K Sell
212
-5
-2% -$4.38K ﹤0.01% 5209
2014
Q2 		$212K Sell
217
-154
-42% -$150K ﹤0.01% 5122
2014
Q1 		$392K Sell
371
-203
-35% -$220K ﹤0.01% 4719
2013
Q4 		$587K Sell
574
-388
-40% -$384K ﹤0.01% 4327
2013
Q3 		$1.23M Buy
962
+874
+993% +$970K ﹤0.01% 3615
2013
Q2 		$74K Buy
+88
New +$77.2K ﹤0.01% 5134

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Morgan Stanley's LSTA Position: Q1 2026 in Review

Morgan Stanley held its Lisata Therapeutics (LSTA) position steady in Q1 2026 at 75 shares worth $376. The position accounts for ﹤0.01% of the portfolio, ranked #7648.

Morgan Stanley first reported a position in LSTA in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.23M in Q3 2013. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • Morgan Stanley held 75 shares of Lisata Therapeutics worth $376 as of Q1 2026.
  • Morgan Stanley left its Lisata Therapeutics share count unchanged in Q1 2026.
  • Lisata Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7648 holding.
  • Morgan Stanley first reported a position in Lisata Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Lisata Therapeutics position peaked at $1.23M in Q3 2013.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.